Plasma uric acid levels in women with cervical intraepithelial neoplasia.
The objective of this study was to determine the association of plasma levels of uric acid, an endogenous antioxidant, in women with cervical intraepithelial neoplasia (CIN), while controlling for the confounding effects of human papillomavirus (HPV) infection, age, smoking, and use of oral contraception. Plasma-reduced and oxidized uric acid levels were determined in 650 women by high-performance liquid chromatography, employing electrochemical technique. The findings demonstrated that 1) plasma-reduced uric acid (PRUA) levels in women with CIN (n = 311) were significantly lower (P < 0.05) compared with women in a control group (n = 339); 2) according to multiple logistic regression analysis, PRUA levels were negatively (P = 0.0113) and HPV infection were positively associated (P < 0.0001) with CIN, after controlling for the confounding effects of the studied factors; 3) according to multiple regression analysis, there was a 31% decrease in CIN risk for each incremental increase of 1mg/dl of PRUA; and 4) according to polychotomous logistic regression analysis, independent of HPV infection, PRUA level was inversely associated with the histopathological graded severity of CIN. We have previously reported decreased plasma levels of exogenous antioxidants, for example, vitamins C and E, in women with CIN independent of HPV infection. The data suggest that plasma deficiencies of several antioxidants in HPV-infected uterine cervical tissue may create an oxidative environment that renders the tissue susceptible to free radical damage. It may be speculated that chronic free radical-induced tissue damage in the context of persistent HPV infection may be involved in the pathogenesis of CIN.
Basu
Jayasri
J
Department of Obstetrics and Gynecology, Albert Einstein College of Medicine, Bronx, NY 10461, USA. jbasu@aecom.yu.edu
Mikhail
Magdy S
MS
Ahn
Chul W
CW
Furguiele
Joseph
J
Ho
Gloria Y
GY
Burk
Robert D
RD
Palan
Prabhudas R
PR
Romney
Seymour L
SL
D000328:Adult; D000368:Aged; D000975:Antioxidants / Q000378:metabolism; D002851:Chromatography, High Pressure Liquid; D003404:Creatinine / Q000032:analysis; D003430:Cross-Sectional Studies; D015344:DNA Probes, HPV; D005260:Female; D006801:Humans; D016015:Logistic Models; D008875:Middle Aged; D027383:Papillomaviridae; D030361:Papillomavirus Infections / Q000097:blood / Q000150:complications*; D012720:Severity of Illness Index; D014527:Uric Acid / Q000097:blood*; D002583:Uterine Cervical Neoplasms / Q000097:blood* / Q000453:epidemiology / Q000209:etiology; D002578:Uterine Cervical Dysplasia / Q000097:blood* / Q000453:epidemiology / Q000209:etiology
D000975:Antioxidants; D015344:DNA Probes, HPV; D014527:Uric Acid; D003404:Creatinine